United Kingdom
Sector: Life Sciences & Therapeutics
Martlet Capital has invested in more than 65 start-ups, since its launch in 2011. In 2021, Martlet successfully raised additional capital to scale its investment activity.
The company provides patient capital for early-stage B2B deep technology and life science start-ups, with a primary focus on companies based in Cambridge.
Disclaimer Investing in start-ups and early-stage businesses involves risks, including illiquidity, lack of dividends, loss of investment and dilution. It should be done only as part of a diversified portfolio. Any investments are targeted exclusively at investors who understand the risks of investing in early-stage businesses and can make their own investment decisions. Any pitches for investment are not offers to the public. Investments made in investee companies via funds managed by Sapphire Capital Partners LLP are not covered by the Financial Services Compensation Scheme (FSCS). For more details, please contact us or refer to their website: https://www.fscs.org.uk |